Company: PIII
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001832511-25-000025
Chunk: 181

Company: P3 Health Partners Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 181
---
 the period are used to calculate the net income or loss attributable to P3 Health Partners Inc. and the non-controlling interest.

P3 Health Partners Inc. | Q3 2025 Form 10-Q | 32

Results of Operations

The following tables set forth our consolidated statements of operations data for the periods indicated. Amounts may not sum due to rounding.Three Months EndedSeptember 30, 2025% of RevenueThree Months EndedSeptember 30, 2024% of Revenue (dollars in thousands)Operating revenue:Capitated revenue$341,555 99 %$357,706 99 %Other patient service revenue3,698 1 4,418 1 Total operating revenue345,253 100 362,124 100 Operating expense: Medical expense369,789 107 401,920 111 Premium deficiency reserve(23,736)(7)18,168 5 Corporate, general and administrative expense22,139 6 27,219 7 Sales and marketing expense251 — 134 — Depreciation and amortization21,033 6 21,673 6 Total operating expense389,476 112 469,114 129 Operating loss(44,223)(12)(106,990)(29)Other (expense) income: — Interest expense, net(20,527)(6)(5,647)(2)Mark-to-market of stock warrants(2,540)(1)5,737 2 Other(2,160)(1)445 — Total other income (expense)(25,227)(8)535 — Loss before income taxes(69,450)(20)(106,455)(29)Income tax (provision) benefit(11)— 3,605 1 Net loss(69,461)(20)(102,850)(28)Net loss attributable to redeemable non-controlling interest(37,874)(11)(56,338)(15)Net loss attributable to controlling interest$(31,587)(9)%$(46,512)(13)%

P3 Health Partners Inc. | Q3 2025 Form 10-Q | 33

Results of Operations

The following tables set forth our condensed consolidated statements of operations data for the periods indicated. Amounts may not sum due to rounding.

Nine Months EndedSeptember 30, 2025% of RevenueNine Months EndedSeptember 30, 2024%